Quick screening of EGFR mutation using restriction fraction length polymorphism
Ichiro Kawada(Keio University), Akitoshi Ishizaka(Keio University), Hideo Watanabe(St. Catherine University), Keigo Kobayashi(Osaka Gakuin University), Ichiro Nakachi(Saiseikai Utsunomiya hospital), Kenzo Soejima(Keio University), Katsuhiko Naoki(Broad Institute), Keisuke Eguchi(Keio University)
Cited by 3
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
<i>Fusobacterium nucleatum</i>and T Cells in Colorectal Carcinoma
|JAMA Oncology|2015|660
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial
|The Lancet Oncology|2019|642
Activating Mutations of the Noonan Syndrome-Associated <b> <i>SHP2/PTPN11</i> </b> Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
|Cancer Research|2004|512
Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers
|Nature Genetics|2015|365